To examine the role of irisin in PD, irisin was peripherally delivered before or after the establishment of MPTP treated mice to explore its effect on neuroprotection and treatment (Fig. 1a, m), in which irisin injection dose was the median dose reported in literature13,17,20,22,23,25–29. This evidence concerns the gene FNDC5 and Parkinson disease.